Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2025)

Stoke Therapeutics has reported Asset Utilization Ratio over the past 4 years, most recently at 0.47 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio rose 265.97% year-over-year to 0.47; the TTM value through Dec 2025 reached 0.47, up 265.97%, while the annual FY2025 figure was 0.53, 265.51% up from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.47 at Stoke Therapeutics, down from 0.55 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.56 in Q1 2025 and troughed at 0.05 in Q4 2022.
  • A 4-year average of 0.2 and a median of 0.06 in 2024 define the central range for Asset Utilization Ratio.
  • Biggest five-year swings in Asset Utilization Ratio: dropped 2.61% in 2024 and later surged 891.2% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.05 in 2022, then rose by 26.28% to 0.06 in 2023, then surged by 120.48% to 0.13 in 2024, then surged by 265.97% to 0.47 in 2025.
  • Business Quant data shows Asset Utilization Ratio for STOK at 0.47 in Q4 2025, 0.55 in Q3 2025, and 0.51 in Q2 2025.